Analysis

Procter & Gamble set to report Q2 earnings next week. Here’s what to expect

Procter & Gamble Company (NYSE: PG) is gearing up for its latest earnings report while navigating a challenging market environment marked by

McCormick (MKC) expected to report higher revenue and earnings in Q4 2025

Shares of McCormick & Company, Incorporated (NYSE: MKC) stayed green on Wednesday. The stock has gained 4% in the past three months.

Earnings Preview: What to watch as Intel (INTC) prepares to report Q4 results

For Intel Corporation (NASDAQ: INTC), 2025 marked a recovery year, as the company made notable progress towards achieving its technological and operational

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

Key metrics from Citigroup’s (C) Q4 2025 earnings results

Citigroup Inc. (NYSE: C) reported its fourth quarter 2025 earnings results today. Revenues increased 2% year-over-year to $19.9 billion, driven by growth in Banking, Services, US Personal Banking (USPB) and

January 14, 2026

INFY Earnings: Infosys Q3 FY26 revenues rise 3%; guides FY26

Tech giant Infosys (NYSE: INFY) reported higher revenues for the third quarter of fiscal 2026. The company also issued guidance for the full fiscal year. Third-quarter revenues increased to $5.1

January 14, 2026

WFC Earnings: All you need to know about Wells Fargo’s Q4 2025 earnings results

Wells Fargo & Company (NYSE: WFC) reported its fourth quarter 2025 earnings results today. Total revenue increased 4% year-over-year to $21.3 billion. Net income grew 6% to $5.36 billion and

January 14, 2026

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top